Celadon Pharmaceuticals PLC (CEL) — Financial Flexibility Index
Celadon Pharmaceuticals PLC (CEL) has a Financial Flexibility Index of -0.21x as of June 2024. Free cash flow of GBX-1.26 Million (operating CF GBX-1.29 Million minus capex GBX29.50K) represents 0% of total liabilities (GBX6.01 Million). Check Celadon Pharmaceuticals PLC (CEL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celadon Pharmaceuticals PLC Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Celadon Pharmaceuticals PLC across 5 annual periods. For the full cash flow conversion analysis, see CEL cash flow metrics.
Annual Financial Flexibility Index for Celadon Pharmaceuticals PLC (2019–2023)
Year-by-year free cash flow to debt coverage for Celadon Pharmaceuticals PLC. Explore CEL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.93x | GBX-5.63 Million | GBX-5.97 Million | GBX6.04 Million | ▼ -44.3% |
| 2022 | -0.65x | GBX-4.01 Million | GBX-6.10 Million | GBX6.21 Million | ▲ +95.1% |
| 2021 | -13.21x | GBX-2.61 Million | GBX-3.15 Million | GBX197.23K | ▼ -7960.8% |
| 2020 | 0.17x | GBX630.67K | GBX-77.57K | GBX3.75 Million | ▲ +21979.9% |
| 2019 | 0.00x | GBX1.98K | GBX1.98K | GBX2.60 Million | — |